Osimertinib Impurity 14 | CAS 1569986-91-9 - Request Quote
Osimertinib Impurity 14
| SZ CAT No: | SZ-O014037 |
| CAS No | 1569986-91-9 |
| Mol.F. | C7H7FN2O3 |
| Mol.Wt. | 186.1 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Osimertinib Impurity 14 is chemically 2-Fluoro-4-methoxy-5-nitroaniline. Osimertinib Impurity 14 is supplied with detailed characterization data compliant with regulatory guideline. Osimertinib Impurity 14 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Osimertinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1569986-91-9
Purchase 1569986-91-9
Order 1569986-91-9
Enquire 1569986-91-9
price of 1569986-91-9
1569986-91-9 Supplier
1569986-91-9 Manufacturer
1569986-91-9 Exporter
buy high quality Osimertinib Impurity 14
Purchase Osimertinib Impurity 14
Osimertinib Impurity 14 suppliers
Osimertinib Impurity 14 manufacturers
Osimertinib Impurity 14 price
Order Osimertinib Impurity 14
Enquire Osimertinib Impurity 14
Osimertinib Impurity 14 cost
Osimertinib Impurity 14 Supplier
Osimertinib Impurity 14 Distributor
Osimertinib Impurity 14 for Method Validation
Osimertinib Reference Standard
Osimertinib Impurity 14 for ANDA Filing
Osimertinib Impurity 14 for Forced Degradation Studies
Osimertinib Impurity 14 Identification Standards
Osimertinib Impurity 14 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


